Literature DB >> 14751567

Interaction of estrogen receptor alpha with protein kinase C alpha and c-Src in osteoblasts during differentiation.

Maurizio Longo1, Marina Brama, Maria Marino, Silvia Bernardini, Kenneth S Korach, William C Wetsel, Roberto Scandurra, Tullio Faraggiana, Giovanni Spera, Roland Baron, Anna Teti, Silvia Migliaccio.   

Abstract

In cultured osteoblasts, protein kinase C (PKC) activity increases and estrogen receptor alpha (ERalpha) binding capacity decreases upon confluence. We investigated potential interactions between ERalpha and PKC isoforms and their confluence-induced modulations in clonal ROS.SMER#14 cells and primary osteoblasts. In sub-confluent ROS.SMER#14 cells, which express an exogenous plus small amounts of the endogenous ERalpha gene, the receptor appeared as two main bands of approximately 66 and approximately 46 kDa. In over-confluent, more differentiated cells, the cytosolic approximately 66 kDa ERalpha appeared decreased and the approximately 46 kDa variant increased. Enhanced expression and/or membrane translocation of PKCalpha and PKCepsilon, but not PKCzeta, was evidenced at over-confluence, along with transient increases in expression and kinase activity of c-Src, accompanied by membrane translocation of the kinase-activated enzyme. In contrast, negligible membrane translocation of PKCalpha and/or activated c-Src was observed in parental ROS 17/2.8 cells, which express low levels of full-length ERalpha. PKCalpha from over-confluent cells phosphorylated p60c-Src in vitro, suggesting functional interaction between the two kinases. ERalpha co-immunoprecipitated c-Src and PKCalpha, mostly in its cleaved form (PKMalpha). An analogous interaction was observed in primary osteoblasts. However, in these cells, much more PKCalpha/PKMalpha was ERalpha-co-immunoprecipitated at over-confluence, a condition in which the shorter, approximately 46 kDa ERalpha variant is increased. This interaction was enhanced by estradiol treatment or PKC down-regulation, but was unaffected by c-Src inhibition. These data highlight direct PKCalpha-c-Src-ERalpha interactions, which may be crucial in the modulation of estrogen responsiveness and the differentiation process in osteoblasts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751567     DOI: 10.1016/j.bone.2003.09.007

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  8 in total

1.  Up-regulation of AMP-activated protein kinase in cancer cell lines is mediated through c-Src activation.

Authors:  Sarit Mizrachy-Schwartz; Noam Cohen; Shoshana Klein; Nataly Kravchenko-Balasha; Alexander Levitzki
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

2.  Membrane-initiated estradiol signaling in immortalized hypothalamic N-38 neurons.

Authors:  Reymundo Dominguez; Phoebe Dewing; John Kuo; Paul Micevych
Journal:  Steroids       Date:  2013-01-05       Impact factor: 2.668

Review 3.  Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy.

Authors:  Wen Zhou; Joyce M Slingerland
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

Review 4.  Endothelial estrogen receptor isoforms and cardiovascular disease.

Authors:  Kyung Hee Kim; Bryan D Young; Jeffrey R Bender
Journal:  Mol Cell Endocrinol       Date:  2014-02-11       Impact factor: 4.102

Review 5.  CFTR activity and mitochondrial function.

Authors:  Angel Gabriel Valdivieso; Tomás A Santa-Coloma
Journal:  Redox Biol       Date:  2013-02-05       Impact factor: 11.799

6.  Estrogens induce expression of membrane-associated estrogen receptor α isoforms in lactotropes.

Authors:  Sandra Zárate; Gabriela Jaita; Jimena Ferraris; Guadalupe Eijo; María L Magri; Daniel Pisera; Adriana Seilicovich
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

7.  Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer.

Authors:  Bethany Perez White; Mary Ellen Molloy; Huiping Zhao; Yiyun Zhang; Debra A Tonetti
Journal:  Mol Cancer       Date:  2013-05-01       Impact factor: 27.401

8.  Protein kinase Cα (PKCα) regulates bone architecture and osteoblast activity.

Authors:  Gabriel L Galea; Lee B Meakin; Christopher M Williams; Sarah L Hulin-Curtis; Lance E Lanyon; Alastair W Poole; Joanna S Price
Journal:  J Biol Chem       Date:  2014-07-28       Impact factor: 5.486

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.